ADC Toxicities: The Price You Pay for Efficacy

Understanding the toxicities associated with antibody-drug conjugates could help oncologists develop strategies to diminish adverse events that arise during treatment with these powerful agents

Related Keywords

Massachusetts ,United States ,Dana Farber Cancer Institute ,Boston ,Paolo Tarantino ,Aditya Bardia ,Massachusetts General Hospital ,Biologic Therapy ,Toxicology ,Cancer Treatment Related Toxicity ,Monoclonal Antibody ,Etuximab ,Ituximab ,Antibody Drug Conjugates Adcs ,Antineoplastic Drug ,Nti Cancer Agents ,Evacizumab ,Rlotinib ,Efitinib ,Matinib ,U11248 ,Unitinib ,Rastuzumab ,Breast Cancer ,Alignant Breast Neoplasm ,Drug Development ,Humanized Monoclonal Antibody ,Tumor ,Cancer ,Saligna ,